Search research articles
Contact Us
Filters
Showing results (151-160 of 209) with videos related to
Page
of 21
Sort By:
Journal of Consulting and Clinical Psychology
|
June 1, 1977
Rapid smoking: a cautionary note
J J Horan, G Hackett, W C Nicholas, et al.
Bone Marrow Transplantation
|
December 20, 2016
Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant
B K Watkins, J Horan, B Storer, et al.
Chemical Communications (Cambridge, England)
|
December 2, 2015
Mechanistic interrogation of the asymmetric lithiation-trapping of N-thiopivaloyl azetidine and pyrrolidine
Peter J Rayner, Joshua C Smith, Charline Denneval, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1993
Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse
P J Horan, B R de Costa, K Rice, et al.
Life Sciences
|
December 20, 1982
Metabolism of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by cell cultures
M C Cabot, M L Blank, C J Welsh, et al.
Irish Medical Journal
|
January 27, 2017
Can 'Hot Spotting' Prove to be a Useful Tool to Identify Disproportionate ED Use in the Rural General Hospital Setting?
E J McGovern, J Bolger, D Courtney, et al.
The Journal of Pediatrics
|
May 1, 1984
Juvenile hypertension: highlights of a workshop
J M Loggie, M J Horan, A R Hohn, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 9, 2023
Sostdc1 Suppression in the Absence of Sclerostin Potentiates Anabolic Action of Cortical Bone in Mice
Roy B Choi, April M Hoggatt, Daniel J Horan, et al.
Aging and Disease
|
December 5, 2022
Targeting Sclerostin and Dkk1 at Optimized Proportions of Low-Dose Antibody Achieves Similar Skeletal Benefits to Higher-Dose Sclerostin Targeting in the Mature Adult and Aged Skeleton
Roy B Choi, April M Hoggatt, Daniel J Horan, et al.
Bone
|
November 9, 2020
Co-deletion of Lrp5 and Lrp6 in the skeleton severely diminishes bone gain from sclerostin antibody administration
Kyung-Eun Lim, Whitney A Bullock, Daniel J Horan, et al.
Page
of 21
Search research articles
Search
Showing results (151-160 of 209) with videos related to
Sort By:
Page
of 21
Journal of Consulting and Clinical Psychology
|
June 1, 1977
Rapid smoking: a cautionary note
J J Horan, G Hackett, W C Nicholas, et al.
Bone Marrow Transplantation
|
December 20, 2016
Recipient and donor age impact the risk of developing chronic GvHD in children after allogeneic hematopoietic transplant
B K Watkins, J Horan, B Storer, et al.
Chemical Communications (Cambridge, England)
|
December 2, 2015
Mechanistic interrogation of the asymmetric lithiation-trapping of N-thiopivaloyl azetidine and pyrrolidine
Peter J Rayner, Joshua C Smith, Charline Denneval, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1993
Differential antagonism of bremazocine- and U69,593-induced antinociception by quadazocine: further functional evidence of opioid kappa receptor multiplicity in the mouse
P J Horan, B R de Costa, K Rice, et al.
Life Sciences
|
December 20, 1982
Metabolism of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine by cell cultures
M C Cabot, M L Blank, C J Welsh, et al.
Irish Medical Journal
|
January 27, 2017
Can 'Hot Spotting' Prove to be a Useful Tool to Identify Disproportionate ED Use in the Rural General Hospital Setting?
E J McGovern, J Bolger, D Courtney, et al.
The Journal of Pediatrics
|
May 1, 1984
Juvenile hypertension: highlights of a workshop
J M Loggie, M J Horan, A R Hohn, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
March 9, 2023
Sostdc1 Suppression in the Absence of Sclerostin Potentiates Anabolic Action of Cortical Bone in Mice
Roy B Choi, April M Hoggatt, Daniel J Horan, et al.
Aging and Disease
|
December 5, 2022
Targeting Sclerostin and Dkk1 at Optimized Proportions of Low-Dose Antibody Achieves Similar Skeletal Benefits to Higher-Dose Sclerostin Targeting in the Mature Adult and Aged Skeleton
Roy B Choi, April M Hoggatt, Daniel J Horan, et al.
Bone
|
November 9, 2020
Co-deletion of Lrp5 and Lrp6 in the skeleton severely diminishes bone gain from sclerostin antibody administration
Kyung-Eun Lim, Whitney A Bullock, Daniel J Horan, et al.
Page
of 21